Upstream Bio (UPB) Income towards Parent Company (2023 - 2025)
Historic Income towards Parent Company for Upstream Bio (UPB) over the last 3 years, with Q3 2025 value amounting to -$33.7 million.
- Upstream Bio's Income towards Parent Company fell 11095.13% to -$33.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$122.2 million, marking a year-over-year decrease of 11352.39%. This contributed to the annual value of -$65.6 million for FY2024, which is 8259.48% down from last year.
- Per Upstream Bio's latest filing, its Income towards Parent Company stood at -$33.7 million for Q3 2025, which was down 11095.13% from -$39.9 million recorded in Q2 2025.
- In the past 5 years, Upstream Bio's Income towards Parent Company registered a high of -$7.9 million during Q3 2023, and its lowest value of -$39.9 million during Q2 2025.
- Its 3-year average for Income towards Parent Company is -$20.8 million, with a median of -$16.0 million in 2024.
- As far as peak fluctuations go, Upstream Bio's Income towards Parent Company plummeted by 6581.06% in 2024, and later crashed by 17222.26% in 2025.
- Upstream Bio's Income towards Parent Company (Quarter) stood at -$12.8 million in 2023, then crashed by 65.81% to -$21.2 million in 2024, then plummeted by 58.78% to -$33.7 million in 2025.
- Its Income towards Parent Company was -$33.7 million in Q3 2025, compared to -$39.9 million in Q2 2025 and -$27.3 million in Q1 2025.